Abbott Laboratories (ABT) and AbbVie Inc. will face lawsuits combined in one Chicago court over claims they hid the risks of using the testosterone booster drug AndroGel. Abbott and AbbVie are both based in the Chicago area and “a significant number” of AndroGel lawsuits already are pending before U.S. District Judge Matthew Kennelly there, according to a panel of judges.